JP2025509950A5 - - Google Patents

Info

Publication number
JP2025509950A5
JP2025509950A5 JP2024556116A JP2024556116A JP2025509950A5 JP 2025509950 A5 JP2025509950 A5 JP 2025509950A5 JP 2024556116 A JP2024556116 A JP 2024556116A JP 2024556116 A JP2024556116 A JP 2024556116A JP 2025509950 A5 JP2025509950 A5 JP 2025509950A5
Authority
JP
Japan
Prior art keywords
xrpd
approximately
degrees
peaks
theta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024556116A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025509950A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/083760 external-priority patent/WO2023179771A1/en
Publication of JP2025509950A publication Critical patent/JP2025509950A/ja
Publication of JP2025509950A5 publication Critical patent/JP2025509950A5/ja
Pending legal-status Critical Current

Links

JP2024556116A 2022-03-24 2023-03-24 Ｐｉ３ｋ阻害剤の結晶形態及び塩ならびにその製造方法及びその使用方法 Pending JP2025509950A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2022082752 2022-03-24
CNPCT/CN2022/082752 2022-03-24
PCT/CN2023/083760 WO2023179771A1 (en) 2022-03-24 2023-03-24 Crystalline forms and salts of a pi3k inhibitor and methods of making and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2025509950A JP2025509950A (ja) 2025-04-11
JP2025509950A5 true JP2025509950A5 (enExample) 2026-04-01

Family

ID=86286092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024556116A Pending JP2025509950A (ja) 2022-03-24 2023-03-24 Ｐｉ３ｋ阻害剤の結晶形態及び塩ならびにその製造方法及びその使用方法

Country Status (8)

Country Link
US (1) US20250197408A1 (enExample)
EP (1) EP4499642A1 (enExample)
JP (1) JP2025509950A (enExample)
KR (1) KR20250044815A (enExample)
CN (1) CN119212996A (enExample)
AU (1) AU2023240100A1 (enExample)
CA (1) CA3246202A1 (enExample)
WO (1) WO2023179771A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220079866A (ko) 2019-09-19 2022-06-14 토투스 메디신스 아이엔씨. 치료 접합체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220079866A (ko) 2019-09-19 2022-06-14 토투스 메디신스 아이엔씨. 치료 접합체

Similar Documents

Publication Publication Date Title
EP3291814B1 (en) An anti-cancer agent 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts
TWI619694B (zh) 用於製備喹啉衍生物之方法
TWI309647B (enExample)
JP7007287B2 (ja) Ｅｇｆｒ阻害薬フリー塩基または酸性塩の多結晶形、その製造方法、および応用
JP2023548859A5 (enExample)
JP5577099B2 (ja) アデニン化合物の製造方法
JP2019524660A5 (enExample)
JP2020511468A5 (enExample)
JPWO2002066445A6 (ja) キナゾリン誘導体
JP2020514361A5 (enExample)
JP2022507251A5 (enExample)
JP2024526882A5 (enExample)
JP2022540922A5 (enExample)
JP2024505063A5 (enExample)
JP2026012715A (ja) ３－（５－フルオロベンゾフラン－３－イル）－４－（５－メチル－５Ｈ－［１，３］ジオキソロ［４，５－ｆ］インドール－７－イル）ピロール－２，５－ジオンの固体形態
JP2024518429A5 (enExample)
JP2023521411A5 (enExample)
JP2025517634A5 (enExample)
TW202024078A (zh) Bet溴結構域(bromodomain)抑制劑之固體形式之製備方法
JP2020083892A5 (enExample)
JP2023548605A5 (enExample)
CN114728923A (zh) 用于制备氧杂环丁烷-2-基甲胺的方法和中间体
US11407759B2 (en) Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
JP2024545695A5 (enExample)
JP2022552329A5 (enExample)